(Q47725050)

5 February 2018

title

DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications. (English)

1 reference

5 February 2018

author

Daniel Rodrigues Furtado

2

1 reference

5 February 2018

Franklin D Rumjanek

8

1 reference

5 February 2018

Claudete Esteves Klumb

object named as

Claudete Esteves Klumb

1

0 references

Raquel Ciuvalschi Maia

object named as

Raquel Ciuvalschi Maia

7

0 references

author name string

Lídia Maria Magalhães de Resende

3

1 reference

5 February 2018

Maria Kadma Carriço

4

1 reference

5 February 2018

Arthur Moellman Coelho

5

1 reference

5 February 2018

Ernesto de Meis

6

1 reference

5 February 2018

publication date

1 August 2003

1 reference

5 February 2018

European Journal of Haematology

published in

1 reference

5 February 2018

volume

71

1 reference

5 February 2018

issue

2

1 reference

5 February 2018

page(s)

81-90

1 reference

5 February 2018

cites work

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

p53, the cellular gatekeeper for growth and division

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Gain of function mutations in p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Correlation between the status of the p53 gene and survival in patients with stage I non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Mutations of the p53 gene as a prognostic factor in aggressive B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

A high frequency of sequence alterations is due to formalin fixation of archival specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Assessing TP53 status in human tumours to evaluate clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Mutations in the p53 gene are not limited to classic 'hot spots' and are not predictive of p53 protein expression in high-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Twenty years of p53 research: structural and functional aspects of the p53 protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Integrating mutation data and structural analysis of the TP53 tumor-suppressor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Mutant p53 gain of function: differential effects of different p53 mutants on resistance of cultured cells to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

Treatment of children and young adults with early-stage non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

The impact of childhood cancer on the United States and the world

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

Clinical significance of p53 mutations in newly diagnosed Burkitt's lymphoma and acute lymphoblastic leukemia: a report of 48 cases

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

p53 gene analysis in childhood B non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

Fast and sensitive silver staining of DNA in polyacrylamide gels

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

Exhaustive analysis of the P53 gene coding sequence by denaturing gradient gel electrophoresis: application to the detection of point mutations in acute leukemias

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

A simple p53 functional assay for screening cell lines, blood, and tumors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0609.2003.00094.X

7 January 2021

10.1034/J.1600-0609.2003.00094.X

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

12890146

1 reference

5 February 2018